sales@angenesci.com
Login | Register
logo
Structures Search
Home Aminos (2R)-2-amino-3-[(3-hydroxypropyl)sulfanyl]propanoic acid

(2R)-2-amino-3-[(3-hydroxypropyl)sulfanyl]propanoic acid

CAS No.:
13189-98-5
Catalog Number:
AG000ZVN
Molecular Formula:
C6H13NO3S
Molecular Weight:
179.2373
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
100mg
95%
In Stock USA
United States
$12
- +
1g
95%
In Stock USA
United States
$13
- +
5g
95%
In Stock USA
United States
$32
- +
25g
98%
In Stock USA
United States
$100
- +
100g
98%
In Stock USA
United States
$300
- +
500g
98%
In Stock USA
United States
$1200
- +
Product Description
Catalog Number:
AG000ZVN
Chemical Name:
(2R)-2-amino-3-[(3-hydroxypropyl)sulfanyl]propanoic acid
CAS Number:
13189-98-5
Molecular Formula:
C6H13NO3S
Molecular Weight:
179.2373
MDL Number:
MFCD00899873
IUPAC Name:
(2R)-2-amino-3-(3-hydroxypropylsulfanyl)propanoic acid
InChI:
InChI=1S/C6H13NO3S/c7-5(6(9)10)4-11-3-1-2-8/h5,8H,1-4,7H2,(H,9,10)/t5-/m0/s1
InChI Key:
KINWYTAUPKOPCQ-YFKPBYRVSA-N
SMILES:
OCCCSC[C@@H](C(=O)O)N
UNII:
UR9VPI71PT
Properties
Complexity:
120  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
0
Exact Mass:
179.062g/mol
Formal Charge:
0
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0
Molecular Weight:
179.234g/mol
Monoisotopic Mass:
179.062g/mol
Rotatable Bond Count:
6  
Topological Polar Surface Area:
109A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-3  
Literature
Title Journal
Peroxynitrite elevation in exhaled breath condensate of COPD and its inhibition by fudosteine. Chest 20090601
Effect of fudosteine on mucin production. The European respiratory journal 20081101
The characterization of selected drugs with infrared laser desorption/tunable synchrotron vacuum ultraviolet photoionization mass spectrometry. Rapid communications in mass spectrometry : RCM 20080801
High-throughput determination of fudosteine in human plasma by liquid chromatography-tandem mass spectrometry, following protein precipitation in the 96-well plate format. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080501
Quantification of fudosteine in human plasma by high-performance liquid chromatography-electrospray ionization mass spectrometry employing precolumn derivatization with 9-fluorenylmethyl chloroformate. Journal of mass spectrometry : JMS 20060501
The pharmacokinetics of orally administered fudosteine in healthy Chinese volunteers. European journal of drug metabolism and pharmacokinetics 20060101
[Pharmacokinetics of fudosteine in healthy volunteers]. Yao xue xue bao = Acta pharmaceutica Sinica 20051001
Inhibition of endotoxin- and antigen-induced airway inflammation by fudosteine, a mucoactive agent. Pulmonary pharmacology & therapeutics 20050101
Effect of fudosteine, a new cysteine derivative, on mucociliary transport. The Journal of pharmacy and pharmacology 20010601
Properties